Medico Remedies Limited (NSE:MEDICO)

Market Cap	3.97B -12.4%
Revenue (ttm)	2.12B +40.7%
Net Income	131.15M +29.9%
EPS	1.58 +29.9%
Shares Out	n/a
PE Ratio	30.24
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	445,670
Average Volume	251,348
Open	47.45
Previous Close	47.12
Day's Range	46.00 - 48.60
52-Week Range	30.22 - 58.99
Beta	0.56
RSI	75.74
Earnings Date	May 21, 2026

About Medico Remedies

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and ster...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 213
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MEDICO

Financial Performance

In fiscal year 2026, Medico Remedies's revenue was 2.12 billion, an increase of 40.66% compared to the previous year's 1.51 billion. Earnings were 131.15 million, an increase of 29.94%.